The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.
STUDY ASSUMPTION YEARS
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
CLINICAL NUTRITION MARKET KEY TAKEAWAYS
- Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.
- Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.
- Oral administration leads the route segment due to convenience, safety, and broad acceptance.
- Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.
- Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.
- Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.
MARKET GROWTH FACTORS
- 1. Rising Chronic Disease Prevalence
Tailored nutrient formulations help improve patient outcomes, reduce complications, and enhance recovery. Hospitals and clinics increasingly integrate medical nutrition therapy into standard care. Patients prefer specialized diets such as low-sugar or low-sodium supplements, driving personalized product innovation. Pharmaceutical and nutrition companies collaborate to develop therapeutic foods, making clinical nutrition a core part of disease management programs.
- Aging Population Growth
Aging leads to decreased nutrient absorption, muscle loss, and weakened immunity. Clinical nutrition products like protein shakes, fortified foods, and vitamin supplements counter malnutrition risks. Healthcare providers focus on geriatric nutrition plans, integrating supplements into long-term care and rehabilitation programs. Market expansion aligns with wellness trends, home healthcare, and assisted living services, emphasizing preventive nutrition.
- Growing Awareness of Malnutrition
Malnutrition impacts immunity, healing, and overall health. Nutritional assessments and interventions are increasingly integrated into treatment protocols. Hospitals and clinics adopt standardized clinical nutrition programs for pediatric, adult, and geriatric patients. Market growth is fueled by public health initiatives, dietitian-led programs, and fortified therapeutic foods addressing nutrient deficiencies.
Request for a sample copy of this report:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
- Infant Nutrition: addresses the dietary needs of newborns with formula and supplements
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
- Oral
- Enteral
- Parenteral
Breakup by Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Breakup by End User:
- Pediatric
- Adults
- Geriatric
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS
Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.
RECENT DEVELOPMENTS & NEWS
Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.
KEY PLAYERS
Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
